Compositions and methods for treating female fertility

Details Compositions and methods for treating female fertility Compositions and methods for treating female fertility

2006-05-09

2006-05-09

Weber, Jon (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C510S350000, C435S007100

Reexamination Certificate

active

07041648

ABSTRACT:
The PTX3 gene or equivalent PTX3 activity is required for female fertility. Manipulation of PTX3 activity will regulate female fertility. The effects of female sterility may be ameliorated, reproductive ability may be increased or decreased as desired, female fertility may be enhanced, or combinations thereof. The need for therapies that affect female fertility is thereby addressed.

REFERENCES:
patent: 99/32516 (1999-07-01), None
Varani Simona et al,; “Knockout of Pentraxin 3, a Downstream Target of Growth Differentiation Factor-9, Causes Female Subfertility”; Molecular Endocrinology, vol. 16, No. 6, Jun. 2002, pp. 1154-1167, XP009002022.

Affiliated with

Also associated with

Rating

Compositions and methods for treating female fertility does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating female fertility, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating female fertility will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3551743